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ABSTRACT
Aim: The overall aim of this PhD thesis was to increase knowledge on the feasibility and 
impact of an educational intervention to shift the management of type 2 diabetes mellitus 
from hospitals to primary health care institutions in rural China.
Study population and methods: All four studies were conducted in Jiangsu province. The 
educational intervention intended to improve collaboration between the hospital and PHC 
level, which would strengthen the knowledge and management of diabetes among primary 
care professionals and in turn lead to improved diabetes knowledge and improved fasting 
blood glucose (FBG) level among patients. Huaiyin, Jingjiang, and Gaochun county were 
selected from north, middle, and south part of Jiangsu Province, respectively. The 
intervention for health care professionals in the intervention areas consisted of three main 
components: team communication, regular meetings, and professional skills training sessions. 
Health care professionals in the control group continued with their routine work and had no 
extra intervention. Patient participants in the intervention areas received services, including 
health education lectures, periodical follow-up interviews with an annual physical 
examination, and special medical services. Patients in the control areas received routine 
services as usual. Baseline data were collected in November 2015, the two follow-up data 
collections were in October 2016 and July 2017, respectively. Questionnaires were used for 
patient participants and staff. Study I and Study II evaluated the one-year impact on the 
patients’ diabetes knowledge, FBG level, and health-related quality of life (HRQoL). Study 
III concentrated on the impact among health care professionals in PHC institutions for one 
year. Study IV assessed the two-year impact on diabetes knowledge and FBG level, among 
patients in the intervention and control group. 
Results: The educational intervention had a positive impact in improving diabetes 
knowledge, lowering FBG levels and improving HRQoL among patients with T2DM at one-
year follow-up. A long-term (two years) positive impact was also found on diabetes 
knowledge and FBG level. The intervention had a differential impact on FBG level for 
patients in different counties, both at the first and second follow-up, and a two-year positive 
impact was found only in Gaochun county. The impact was also greater among certain 
patient groups, especially among females, married persons, low educated persons, and those 
in farming or house working. Moreover, the intervention had a positive impact among health 
care professionals in PHC on their professional diabetes knowledge, attitudes and practices 
regarding the intervention, and types of services they were able to provide.  
Conclusions: The educational intervention, with improved collaboration between county 
hospitals and PHC institutions, and health education to patients, resulted in improved diabetes 
knowledge and FBG levels and improved some aspects of HRQoL among patient 
participants. The impact of the intervention was greater among certain patient groups and 
differed between the counties. The intervention had a positive impact among health care 
professionals in PHC on their professional diabetes skills, knowledge, attitudes, practices, and 
types of services they were able to provide. Improved collaboration between county-level 
hospitals and PHC, with educational efforts both to health care staff and patients with T2DM, 
appears to be a feasible and effective way of improving care of patients with T2DM in rural 
areas in China. 
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11 BACKGROUND
1.1 GLOBAL BURDEN OF TYPE 2 DIABETES MELLITUS (T2DM)
Type 2 diabetes mellitus (T2DM) is becoming one of the most common chronic diseases all 
around the world (1), 8.5% of adults aged 18 years and older had diabetes in 2014 globally, 
more than 90% of whom had T2DM (1,2). It is estimated that by the year 2040, more than 
642 million people might suffer from T2DM (2). Meanwhile, the prevalence of T2DM varies 
according to geographical region. The Eastern Mediterranean and the Middle East have the 
highest rate of T2DM, while India and China have the highest number of T2DM patients (3). 
The aging population, rapid urbanization, the unhealthy lifestyle, with increasing overweight 
and obesity are considered as possible reasons for the high prevalence of T2DM (4).
The low- and middle-income countries (LMICs) are facing a more difficult situation of 
T2DM than developed countries, and 80% of the T2DM patients live in the LMICs (2). A 
nutrition transition towards consumption of refined carbohydrates, high total fat, along with 
low intake of fiber was detected in many LMICs (5). The nutrition transition is considered to 
be strongly related to the increases in obesity, metabolic syndrome, and T2DM (6). 
Meanwhile, people in LMICs usually have low awareness on T2DM and its risk factors, as 
many of them are illiterate, or rural residents (7,8). Not only the poor awareness of T2DM, 
but also lack of information on healthy lifestyle, low-level of education, and limited access to 
blood testing are posing a huge obstacle to the prevention and management of T2DM (8). 
More seriously, the overall health care budget in LMICs remains low and focused more on 
communicable diseases, while the number of patients with T2DM and other chronic diseases 
has increased sharply (9,10). In many LMICs, little policy support, insufficient access to 
medical professionals, and poor affordability of medicine is hindering the development of the 
health care system for T2DM patients (11).
1.2 BURDEN OF T2DM IN CHINA
As one of the largest LMICs, China is also experiencing a dramatic increase in T2DM since 
1980 (12). After the reform and opening-up policy in 1978, the standard of living of Chinese 
people has improved remarkably (12). However, the dramatic urbanization, the aging 
population, the rapid change of lifestyle, with increasing overweight and obesity has led to 
the rapid increase of T2DM in China (13). China conducted its first nationwide diabetes 
epidemiological survey in 1980, with a prevalence rate of only 0.7% (14). In 2013, the 
prevalence rate had increased dramatically to 11% (13,15). Older age, family history of 
T2DM, binge drinking, overweight, and obesity were all positively associated with T2DM 
prevalence in China (16). On the other hand, a healthier lifestyle (more vegetable and fruit 
intake, and more frequent physical activity), and higher education were protective factors of 
T2DM (16).
Prediabetes is the states which is defined by blood glucose level higher than normal, but 
lower than established thresholds for diabetes itself (17). Prediabetes is a high-risk state not 
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complications, nephropathy, and neuropathies (17). It was estimated that 470 million people 
may have prediabetes by 2030 (17). Prediabetes becomes a huge threat for Chinese adults as 
well (16). It has been reported that nearly 36% of the population had prediabetes, indicating 
that more than 350 million people may develop T2DM if they do not change their lifestyle 
(18). Apart from the suffering caused by T2DM, a number of severe complications, including 
cardiovascular complications, nervous system disorders, and diabetic nephropathy, may also 
threaten patients (19).
The situation regarding T2DM in rural China is even worse, with a faster increasing rate of 
prevalence than in the urban areas, while the awareness and opportunities for treatment and 
control of T2DM are inadequate in rural areas (20). A trend was found that the epidemic peak 
of diabetes is slowly moving from major cities to small cities and rural areas in China, since 
2007 (21). Proper and adequate diabetes care may not be accessible as the majority of the 
rural residents live in low-income conditions (22). The older patients often have low 
educational level or are even illiterate, which results in a poor quality of self-monitoring of 
blood glucose level, and low adherence to antidiabetic medications or insulin injections (23). 
Furthermore, an unbalanced lifestyle becomes another risk factor for rural residents, 
especially farmers (22). During planting and harvest seasons, farmers usually consume more 
sugar to deal with the heavy workload. On the other hand, during the traditional holidays such 
as Chinese New Year, they prefer to have high fat and oil dishes to celebrate the festival 
without any physical exercise (22).
1.3 THE HEALTH CARE SYSTEM IN CHINA
Under the health legislative system controlled by the National People’s Congress (NPC), the 
Chinese health care system consists of health governing system, health service delivery 
system, and health financing system (24). The Health and Family Planning Commission 
(HFPC) and the Administration of Traditional Chinese Medicine (ATCM) compose the main 
body of the health governing system (24). The health delivery system is divided into two 
parts: the public health system and the medical service delivery system. The public health 
delivery system includes Centres for Disease Control (CDC), health education facilities 
(medical colleges and university-affiliated hospitals), and health supervision and management 
institutions (such as the Insurance Regulatory Commission and Ministry of Civil Affairs). 
(24). The medical service delivery system is composed of hospitals at different levels and 
primary health care facilities (24). Government input dominates the health financing system 
(24). 
Chinese residents now have three main types of health insurance: the Urban Employee Basic 
Medical Insurance (UEBMI), Urban Residence Basic Medical Insurance (URBMI), and the 
New Rural Cooperative Medical Scheme (NRCMS) (24). Twenty years after the health care 
reform, 95% of Chinese population was covered by the three health insurances (25). The 
UEBMI is established for the urban residents who work in the formal sector (26) and is 
financed by payroll taxes from both employers (6%) and employees (2%) (26). It is a 
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Individual Account (26). The URBMI is targeted for other urban residents. It includes, in 
particular, children, students, unemployed people, and migrant workers (26). The URBMI is 
a voluntary scheme financed by the insured residents and local government (26). The 
URBMI contains a Social Pooling Account for inpatient care and a Household Account for 
outpatient care (26). All rural residents can voluntarily participate in the NRCMS with local 
government (26). Similar to the URBMI, the NRCMS also has a Social Pooling Account and 
a Household Account (26). The reimbursement ratio of all three types of health insurance is 
increasing every year. In 2015, the inpatient care reimbursement ratio was 69% for the 
UEBMI, 53% for the URBMI, and 50% for the NRCMS (27). 
Figure 1 illustrates the health care system in rural and urban China. The health care system in 
rural areas contains three different levels of care: county level, township level, and village 
level (24). Primary health care (PHC) in rural China consists of township health centres and 
village clinics, and almost all of them are publicly owned (28). The PHC institutions are the 
fundamental elements for providing generalist clinical care and basic public health services, 
as they offered 55% of outpatient care and 18% of inpatient care in 2016 (28,29). The PHC 
has been proven to be a critical factor for the effective management of chronic diseases, 
especially in LMICs (30,31). 
However, the health care system and PHC in rural China are still facing challenges. The 
quality of PHC is poorly assessed, as few studies focused on the quality issue concerning 
outcome measures (28). The health care professionals from PHC institutions usually have 
low levels of training (also regarding chronic diseases), commonly in the lower level medical 
education, and have a heavy workload (28). The medical training for PHC doctors consists of 
three levels: medical college, junior medical college, and technical school (28). However, the 
majority of health care professionals in rural China only receive a three-year medical 
education in medical technical school or junior medical college and lack access to updates in 
medical knowledge and skills (32). Moreover, health care professionals in PHC are paid low 
wages and have minimal benefits, and high-quality care is not rewarded as well (24,32). 
Doctors prefer leaving the PHC institutions, and many doctors in village clinics work over 
their retirement age (24).
4Figure 1. The health care system in rural and urban China (33)
1.4 HEALTH CARE REFORMS 2009−2020 AND “HEALTHY CHINA 2030” 
After the market-oriented economic reforms and opening-up in 1978, the health care system 
also experienced a set of reforms (24). Market forces were introduced into the health care 
system: private health clinics were established, while some public-owned health care 
facilities were privatized (34). One of the impacts was that health care facilities became 
profit-driven, which led to a rapid increase in out-of-pocket medical expenditure (24). PHC 
was designed to conduct chronic care services, including for diabetes (36). However, costly 
hospital care remained dominant, and little collaboration was implemented between hospitals 
and PHC institutions especially in rural China (24,35). Due to the uneven distribution of 
health care resources, affordable and adequate diabetes care is lacking in rural China, or 
diabetes patients seek cheap but inappropriate care (36).
In response to the existing challenges, the central government launched an ambitious health 
care reform in 2009 (37). It aimed to provide universal coverage of essential health care 
services for all Chinese residents by 2020, with three sequential phases (38). From 2009 to 
2012, the reform concentrated on five main targets: expanding public health insurance, 
strengthening primary care, establishing essential medicine program, providing public health 
care services, and pilot reforms of public hospitals (39). The second phase started in 2012 and 
ended in 2015, with a particular focus on public hospital reform (37). The health reform 
entered its third phase from 2015, and the ultimate goal was reconfirmed by the central 
government (37). The reform pushed the governments at all levels in China to put their 
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unifying the three public insurance schemes: UEBMI, URBMI, and NRCMS to reduce the 
out-of-pocket health care expenses (24,37). 
Moreover, the central government implemented another health policy “Healthy China 2030” 
blueprint in 2016, as an important part of the Sustainable Development Goals (SDGs) (40). It 
concerns not only the medical care for people’s health, but also includes broad determinants 
such as environmental health, lifestyle, and health education (37,41). As one of the main 
threats to Chinese people, non-communicable diseases including diabetes, was especially 
focused in the “Healthy China 2030” blueprint (42). One of the major health targets is to 
enhance the collaboration between hospitals and PHC to provide diabetes care for patients 
(42).
1.5 INTERVENTION STUDIES FOR T2DM CARE GLOBALLY
Various types of intervention studies have been carried out in order to improve T2DM care 
globally (43-47, 50-55). Self-management including self-monitoring of blood glucose and 
peer support was used and showed a positive impact in controlling blood glucose level and 
improving diabetes knowledge (43,44). In recent years, new technology such as smartphone 
applications have been introduced in intervention studies for T2DM (45-47). It has been 
suggested that mobile and smartphone technologies could be an effective tool, as it is 
convenient in sharing data, enhancing communication, and improving glycemic control 
(46,47).
It is considered important to help diabetes patients to obtain the knowledge, skills, and 
abilities required for effective and sustained self-management (48). Therefore, educational 
interventions for people with T2DM is becoming another focus (49). T2DM education 
enables patients to acquire knowledge to modify their behaviour and to self-manage their 
conditions (48,50). Many educational intervention studies have been conducted in high-
income countries (50-52). One study assessed the impact of an intervention in Sweden where 
patients in the intervention group received an empowerment group education for one year 
(51). Compared with the patients in the control group who received routine services, the 
empowerment group education improved patients’ confidence in diabetes knowledge, and 
helped control the blood glucose level (51). Studies with similar designs are also found in 
LMICs, with a positive impact on strengthening patients’ diabetes knowledge and changing 
lifestyles. Some of them have also reported that the educational intervention improved 
patients’ health outcomes such as blood glucose level (53,54).
A systematic review of educational intervention studies all over the world, found that 
educational interventions significantly improved participants regarding self-efficacy, diabetes 
knowledge, while the impact on blood glucose level and body mass index (BMI) varied (55). 
The study recommended more involvement of the patient, and the educator should be trained 
beyond the primary preparation for the self-management program (55).
61.6 INTERVENTION STUDIES FOR T2DM CARE IN CHINA
There is growing concern about diabetes care in China in recent years (56). Along with the 
encouragement from the health care reform, different types of interventions with the aim of 
preventing and managing diabetes, have been implemented in order to improve the services 
for diabetes patients in China (56-57). Similar to the trends globally, educational 
interventions have also been implemented in China (58-63). Most of those studies have been 
performed in urban areas, with a relatively short duration (less than one year). Few studies 
have been done in rural China, and studies of the long-term impact of the educational 
intervention are lacking (61-63). A nutritional education intervention was conducted in a 
suburb area in Inner Mongolia Autonomous Region (63). After six-months of the 
implementation of the intervention, patients’ nutrition knowledge, awareness and practice 
accuracy improved significantly. Patients’ lifestyle also changed, having more healthy diets 
(63).
In most of the educational interventions, health care professionals usually act as the diabetes 
educator, who should be equipped with in-depth knowledge and skills, communication, and is 
to teach patients to manage daily conditions (48). Therefore, the educational intervention 
should include the aim of improving health professionals’ medical knowledge and skills, as 
well as the ability to provide different types of diabetes services. However, there are only a 
few educational intervention studies that concentrate on health care professionals, especially 
those in PHC institutions (64-66). A training session was implemented for PHC doctors in 
eastern China. After 18 months, there was an improvement in professional skills and an 
increasing ability to provide a better quality of diabetes care (64).
As described above, knowledge is still lacking regarding the impact of educational 
interventions, among both diabetes patients and health professionals in PHC institutions. Few 
studies have focused on rural China. A review found that many educational interventions in 
China did not address the patient’s behaviour change, health-related quality of life (HRQoL), 
body mass index (BMI), blood pressure, lipids, or medical costs (67). Long-term outcomes 
and adherence to diabetes education were vague and there were few studies on those topics 
(67).
This PhD thesis is nested in the project “Studying the Vertical Integration Strategy of Chronic 
Disease Service Based on Multiple Incentive Mechanism in Rural China” 
(ISRCTN13319989), conducted by Nanjing Medical University (NMU) (69). The project 
intended to shift the care of T2DM and primary hypertension from hospital to PHC, through 
implementing, together with the county-level hospital, an educational intervention for 
patients and health care professionals in PHC institutions (Figure 2). The green square in 
Figure 2 shows the position of the PhD thesis in the project, assessing the impact of the 
educational intervention.
7Figure 2. Logic model of the project “Studying the Vertical Integration Strategy of Chronic 
Disease Service Based on Multiple Incentive Mechanism in Rural China” (69)
82 AIM
2.1 OVERALL AIM
The overall aim of this thesis was to increase knowledge on the feasibility and impact of an 
educational intervention to shift the management of type 2 diabetes mellitus from hospitals to 
primary health care in rural China.
2.2 RESEARCH QUESTIONS
1. How did the intervention influence:
a) patients’ fasting blood glucose level and health-related quality of life? (Study I)
b) patients’ diabetes knowledge and fasting blood glucose level? (Study II)
c) knowledge of diabetes care, attitudes towards the intervention, and services provided 
among health care professionals in primary health care institutions? (Study III) 
2. What was the long-term (two years) impact on fasting blood glucose level and diabetes 
knowledge among patients? (Study IV)
An overview of Study I-‒IV is shown in Table 1.
Table 1. Overview of the four studies
　 Study I Study II Study III Study IV
Study population T2DM patients T2DM patients
Health care 
professionals in 
PHC
T2DM patients
Study setting
(counties) Jingjiang 
Huaiyin 
Jingjiang 
Gaochun 
Huaiyin 
Jingjiang
Gaochun 
Huaiyin 
Gaochun
n=423 n=1305 n=241 n=783
Sample size and 
data sources Baseline and 
first follow-up
Baseline and 
first follow-up
Baseline and 
first follow-up
Baseline, first and second 
follow-up
Outcomes FBG
* and 
HRQoL**
Diabetes 
knowledge and 
FBG
Professional 
knowledge; 
perspective on 
the intervention; 
provided 
services
Diabetes knowledge and 
FBG
* FBG = Fasting blood glucose level
**HRQoL = Health-related quality of life
93 STUDY POPULATION AND METHODS
3.1 STUDY SETTING: JIANGSU PROVINCE
All four studies were conducted in Jiangsu province, located in the east part of China (Figure 
3). Jiangsu province covers 107,200 km2 with 80.5 million population in 2018 (70). Jiangsu 
province consists of 13 prefecture-level cities and 96 rural county administrative divisions 
(counties) that belong to the prefecture-level cities (70). Jiangsu province is known as “land 
of fish and rice”, as it was China's major rice and fish producing areas in history (71). Since 
the reform and opening policy in 1978, Jiangsu province has become one of the most 
important industrial regions in China, with the second-largest gross domestic product among 
all provinces (70,71). Jiangsu province is divided into three parts according to geographical 
factors and economy: the north part (less economically developed), the middle part (average 
economically developed), and the south part (most economically developed) (72). The 
economic, education and health indicators in rural areas of Jiangsu province are all above the 
average level in China (70).
Jiangsu province is facing a serious situation of T2DM as the economy and lifestyle changed 
considerably in the last 30 years (Figure 4) (73). In 2009, the prevalence of T2DM was 8.5%, 
which was slightly lower than the prevalence rate in the whole country (74). However, the 
prevalence rate had increased sharply both in urban and rural areas in Jiangsu province. The 
number of T2DM patients increased 1.3 times compared with the number in 2002 (74). The 
south part of Jiangsu province has the highest prevalence rate, and the north part has the 
second-highest prevalence rate (74). In addition to the impact on health of T2DM, it was also 
estimated that the indirect economic losses caused by diabetes were 740 million RMB in 
2010 (74,75). Although the T2DM prevalence rate in rural Jiangsu province is lower than in 
the urban areas, the insufficient diabetes care resources, the fast-increasing prevalence, and 
the poor awareness of diabetes are obstacles to improving people’s health in rural Jiangsu 
province (74). Therefore, there is an urgent need to strengthen prevention and treatment of 
T2DM in rural areas in Jiangsu province.
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Figure 3. Prevalence of T2DM in geographic areas of China (73)
Figure 4. Map of all 13 prefecture-level cities in Jiangsu province, China 
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3.2 SELECTION OF INTERVENTION AND CONTROL AREAS, AND 
PARTICIPANTS
The research team in Nanjing Medical University (NMU) was responsible for selecting 
counties for the study. One county was randomly selected in 2015 from each part of Jiangsu 
province. Huaiyin county was selected from 37 counties in the north part. Jingjiang county 
was selected from 11 counties in the middle part. In the south part, Gaochun county was 
selected from 39 counties. There are 14 townships in Huaiyin county (70). Jingjang and 
Gaochun counties have eight townships, respectively (70).
After the selection of counties, the local HFPC in those three counties were asked to 
participate in the project and were responsible for selecting of townships. In each of the 
counties, 2–4 townships were randomly selected as the intervention areas. Subsequently, 
according to the socio-demographic features, the economic development situation, and the 
health care services, 2–4 townships were selected in the same county as the control areas. 
Finally, 18 townships (nine intervention, nine control) were part of the study. Table 2 shows 
the counties and townships, which took part in the project.
Table 2. The counties and townships selected in the project
Implementation
Location County Intervention township 　Control township One year Two years
Nanchenji YangzhuangNorth Huaiyin Zhaoji 　Yuanji * # *
Dongxing Chengnana
Houhe GushanMiddle Jingjiang
Xieqiao
　
Huifeng
* #
Qiqiao Chunxi
Zhuanqiang Yaxi
Yangjiang GubaiSouth Gaochun
Dongba
　
Gucheng
* # *
* Intervention for patients with T2DM
# Intervention for health care professionals in PHC
The recruitment of patient participants was non-randomized. Doctors from township health 
centres contacted T2DM patients living in the townships, who satisfied the inclusion criteria 
according to their records. The inclusion criteria were: meeting the diagnostic criteria of the 
Chinese Guidelines on the Prevention and Treatment of T2DM (13); aged 35–75 years old; 
living in the current county for more than two years with no records of moving within the last 
year; having personal records in the chronic disease management information system in the 
township health centres; taking the chronic disease service provided by the primary care 
institutions; and willing to participate in the project and having preferable cognition and 
receptivity. Patients were excluded if they had severe diabetes complications, or they were 
diagnosed with any other severe disease, or they were pregnant or had psychiatric disorders.
The selection of the health care professional participants was conducted under the principle of 
voluntariness. Health care professionals in PHC institutions were invited to the project in 
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both the intervention and control areas. The inclusion criteria were: that they were frontline 
staff (not administrative or personnel staff); were willing to take part in the data collection; 
worked in the current institutions for at least two years; had no plan to leave. 
3.3 THE IMPLEMENTATION OF THE EDUCATIONAL INTERVENTION
The intervention was designed by the NMU research team at the beginning of 2015 and was 
revised and improved by suggestions from HFPC, county-level hospitals, and Jiangsu 
Provincial Centres for Disease Control and Prevention. The implementation of the 
intervention began in November 2015, after the baseline data collection in October 2015. 
The intervention for T2DM patients was designed to be conducted for two years in three 
selected counties, with collection of baseline data in 2015, and at the end of each year, one 
follow-up data collection would be carried out (Table 1). However, Jingjiang county 
discontinued the intervention at the end of 2016 due to administrative reasons. Finally, the 
intervention was conducted for two years in Huaiyin and Gaochun counties, with the first 
follow-up data collection in October 2016, and second follow-up data collection in July 2017. 
In Jingjiang county, the intervention was conducted for one year, with one follow-up data 
collection in October 2016. 
The underlying logic of the educational intervention was to improve collaboration between 
the hospital and PHC level, with educational lectures and follow-up services to patients, 
which would in turn lead to improved diabetes knowledge and improved fasting blood 
glucose (FBG) level among patients. Professional skills training, team discussions, and 
regular meetings to discuss work progress would strengthen the knowledge and management 
of diabetes among PHC professionals.
The educational intervention was conducted by service teams, assembled by the county-level 
health authorities in the intervention areas. The service teams consisted of physicians, nurses, 
public health physicians, and diabetes specialists from all three levels of rural health care 
institutions (county-level hospitals, township health centres, and village clinics).
3.4 THE EDUCATIONAL INTERVENTION FOR PATIENTS WITH T2DM
In addition to the routine services, patients in the intervention areas received health education 
lectures, periodical follow-up interviews with an annual physical examination, and special 
medical services (i.e. helping patients with medical treatment, transfer treatment, return visits, 
and clinical care).
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The education lectures were held every two months, usually lasted for about two hours for 
patients in the intervention group. The service teams used specific patient examples to make 
the lecture easy and interesting for the patients. The lectures included: 
 basic information on diabetes, including typical symptoms, the basic epidemiological 
facts, the basic diagnosis criteria, and diabetes-related complications, such as foot ulcers;
 self-management strategies, including self-monitoring blood glucose at home, food 
recommendations, and suggestions about how to use medication; 
 instruction on physical exercise and diet therapy; 
 risk and dangers when having high blood glucose level,  the need for balancing sugar, 
protein, and fat intake; 
 recommendation on quitting smoking and drinking, eating bean products, and controlling 
cholesterol intake; 
 prevention of diabetes, based on the Triple Prevention strategy of Diabetes (TPD), as 
recommended by the guidelines for T2DM in China (13). 
Periodical follow-up interviews were offered every two months. Doctors in township health 
centres paid a home visit and measured blood glucose level among patients in the 
intervention area. The doctors also provided counselling according to blood glucose level and 
patients’ eating or physical exercise records. Patients could also give feedback on their 
attitudes and feelings about the education lecture they had taken part in. County-level 
hospitals provided the annual physical examination. The examination contained a “routine 
package” (height, weight, blood pressure, and electrocardiogram), a “physical examination 
package” (ophthalmology, otolaryngology, and stomatology, etc.), and a “biochemical 
examination package” (blood test, liver and kidney function tests, blood glucose and blood 
lipid test, and test for some tumour markers). The annual physical examination was free for 
patients in the intervention area, the project and the county-level hospitals covered the fee.
Township health centres in the intervention areas took responsibility for the special medical 
services, which included helping patients with medical treatment, transfer treatment, return 
visits, and clinical care. 
Patients in the control areas received routine services as usual, including clinic visits to a 
physician and referrals as required according to the patient’s condition, FBG test every four 
to six months, and receiving diabetes knowledge leaflets once a year.
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3.5 THE EDUCATIONAL INTERVENTION FOR HEALTH CARE 
PROFESSIONALS IN PHC
The intervention for health care professionals in the intervention areas consisted of three main 
components: team communication, regular meetings, and professional skills training sessions.
The team communication and regular meetings aimed to bring together doctors in the county-
level hospital health care system and those working in the PHC system and to improve the 
diabetes service to patients. Some special cases were discussed during the team 
communication, and doctors in the county-level hospitals suggested the work plan of health 
care professionals in the PHC institutions during the regular meetings. 
The professional skills training sessions were provided by the county-level hospitals and were 
designed to improve the professional skills and knowledge for those in PHC institutions in 
the intervention areas. The detailed contents of the training sessions were decided by each 
county-level hospital, and mainly focused on effective management of diabetes patients, 
instruction about diabetes medication and insulin injection, and using the unified health 
information system to record patients’ situations. After the intervention, health care 
professionals in PHC institutions were expected to have increased knowledge on diabetes and 
provide more types of diabetes care services than before.
Health care professionals in the control group continued with their routine work and had no 
extra intervention.
3.6 OUTLINE OF THE FOUR STUDIES
The outline of Study I‒IV is illustrated in Figure 5. Study I, Study II, and Study IV focused 
on the impact among patients with T2DM, while Study III concentrated on the impact among 
the health care professionals in PHC institutions. Study I and Study II evaluated the one-year 
impact on the patients’ diabetes knowledge, FBG level, and HRQoL. Study IV assessed the 
two-year impact on diabetes knowledge and FBG level, compared with patients in the control 
group, after the implementation of the intervention. 
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3.7 DATA COLLECTION
All four studies used the database collected in the larger project. Questionnaires were used to 
collect data; one was for patients with T2DM, and two were for health care professionals 
(69). The questionnaires are found in the Appendix. 
The questionnaire for patients contained information regarding socio-demographic 
characteristics, diabetes knowledge (nine questions), and the HRQoL instrument EQ-5D-3L. 
The patients’ socio-demographic characteristics included age (in years); sex (male vs. 
female); marital status (married/cohabiting vs. single); level of education (low vs. high); 
occupation type (farmer/housework vs. other); and the duration (in years) of being diagnosed 
with T2DM. Participants with primary school or less were classified as having low education; 
those with higher than primary school (middle school/high school/junior college/bachelor or 
higher) as having high education. Participants’ blood glucose level was measured with a 
venous blood sample after completing the questionnaire.
For health care professionals, one questionnaire was used to collect participants’ socio-
demographic information, diabetes professional knowledge (13 questions), and eight 
questions related to services which the health care professionals provided to the patients. The 
other questionnaire was on attitudes (three questions) and practices (six questions) regarding 
the intervention. Each of the nine questions had five response levels: from the worst to the 
best. Participants’ socio-demographic information was collected concerning age (in years), 
working experience (in years), sex (male vs. female), and medical education level (low vs. 
high). Participants with technical school degree or junior medical college degree were 
classified as having low medical education; those with medical college degree or higher 
degree as having high medical education.
The research team from NMU took the responsibility of collecting data. Face-to-face 
interviews were carried out with the patients. Before the data collection, research team 
members were trained how to clarify, if needed, the questions to patients and how to avoid 
misleading the patients when explaining. During the data collection, patients were told that no 
other patient participants would know the answers they provided, and their personal 
information was not recorded in the questionnaire. After each data collection, patients 
received a small gift (a towel) for participation reward. The health care professionals in PHC 
who participated in the intervention, were asked to complete the two questionnaires by 
themselves. They were not allowed to talk with other participants during answering the 
questionnaires. The county-level HFPC offered a special bonus to them for participating in 
the project.
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3.8 OUTCOME MEASURES USED IN THE STUDIES
Blood glucose level (Study I, II, IV)
FBG level and glycated hemoglobin (HbA1c) are commonly used to measure the blood 
glucose level for T2DM (76-78). There are some discussions about the sensitivity and 
effectiveness between FBG level and HbA1c, but the conclusion varies (79-85). One study 
conducted in Taiwan found that HbA1c is more sensitive than FBG in detecting unusual 
blood glucose level (81). In contrast, another study in the United States found that FBG is 
more effective when separating diabetes patients from non-diabetes patients HbA1c (85). It is 
suggested that the combined use of FBG and HbA1c is a better way to monitor blood glucose 
level for patients with T2DM (84).
Blood glucose level in this project was measured by FBG level, because it is less expensive 
and easier to obtain than HbA1c in the rural areas. Some of the township health centres were 
not able to conduct the HbA1c test, and HbA1c was not collected at baseline in Jingjiang 
county.
Patients’ diabetes knowledge (Study II, IV)
There are several existing questionnaires for measuring patients’ diabetes knowledge, 
including Diabetes knowledge Scale (DKN-A), Diabetes Knowledge Questionnaire (DKQ-
24), and Diabetes Knowledge Test 2 (DKT2) (86-88). In the current project, DKN-A was 
considered too difficult for our participants to understand as most of them had low 
educational level. DKQ-24 was considered out of date, as it was developed in 1983 (87). 
Although DKT2 is a newly designed questionnaire, it contains many questions and might 
take too long for participants to answer along with other questions related to T2DM. 
As a result, the research team from NMU decided to add nine self-designed questions for 
diabetes knowledge in the current questionnaire for patients. The nine questions included 
basic knowledge on diabetes, self-management, and healthy lifestyle. A diabetes knowledge 
score was calculated based on response to nine questions (correct answer marked as 1, wrong 
answer marked as 0). The nine questions were pilot-tested before use, the Cronbach alpha 
was 0.76. The specific questions are shown in Appendix Table 1.
Health-related quality of life (Study I)
In Study I, HRQoL was used to evaluate the impact of the intervention among patients. 
Different types of instruments can be used to measure HRQoL, both in the general population 
and  among diabetes patients (89-91). The World Health Organization Quality of Life 
Assessment Instrument (WHOQOL-100) and the EQ-5D can be used in the general 
population or among individuals with different health conditions (89,90). In contrast, the 
Diabetes Quality of Life measure (DQOL) is designed specifically for diabetes patients (91). 
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The generic HRQoL instrument EQ-5D-3L consists of two parts: a descriptive system and a 
visual analogue scale (EQ VAS) (90). The EQ VAS records the patient’s self-rated health on 
a vertical VAS, where the endpoints of the scale are 0 (worst imaginable health state) and 100 
(best imaginable health state). The descriptive system of EQ-5D-3L contains five different 
dimensions of health: mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression. Each dimension has three different levels of severity: no problems, some 
problems, and extreme problems. There are 243 different health profiles that can be created to 
describe the health status from the descriptive system (92). Those unique health profiles can 
be converted into a single index value by a value set, where full health is 1 and dead is 0 (92). 
Various national value sets have been developed by different methods (such as the time trade-
off (TTO) method and the VAS method) (92). 
There are three value sets developed based on a Chinese population (93-95). The value sets 
developed by Liu et al. (93) and Zhuo et al. (94) used the TTO method for health states that 
were described to those who valued them, and the study by Liu et al. was based only on an 
urban population. Sun et al. have developed a value set using the VAS method for health 
states that were currently experienced by the respondents in the general population (95). In 
Study I, we employed the experience-based VAS value set developed by Sun et al. to 
calculate the EQ-5D-3L index.
Health care professionals’ diabetes knowledge and services they can provide (Study III)
We did not find any studies published in international journals about the impact of education-
based interventions among T2DM medical professionals. Therefore, we decided to design 
and use two questionnaires for collecting data related to health care professionals’ 
knowledge, services they can provide, and their perspective on the intervention. 
In Study III, one structured questionnaire was used, which contained 13 questions related to 
diabetes professional knowledge and eight questions related to services which the health care 
professionals provided to the patients. A knowledge score was calculated as a sum of correct 
answers to each of the questions, with the total score 13 points. The Cronbach alpha for the 
professional knowledge questions and for the services type which the health care 
professionals provided was 0.71 and 0.82, respectively. The 21 questions related to 
professional knowledge and services the health care professionals can provide are shown in 
Appendix Table 2 and Appendix Table 3, respectively.
Professionals’ perspective of the intervention (Study III)
Another questionnaire on attitudes and practices regarding the intervention was also used in 
Study III to measure health care professionals’ perspectives on the intervention. It included 
four sections: conducting transfer treatment, evaluating cooperation with higher-level 
hospitals, general perspective about PHC institutions, and evaluating factors that affected the 
integrated care service. We extracted nine questions and divided them into two parts: 
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attitudes change (three questions), and participants’ perspective on their practice before and 
after the intervention (six questions). All the nine questions had five response levels: from the 
worst to the best. 1 to 5 points were given to each question, in which 1 represented the worst, 
and 5 represented the best. Participants obtained an attitude score (total maximum score: 15 
points) and a practice score (total maximum score: 30 points). The nine questions have been 
pilot-tested, the Cronbach alpha was 0.84. The questions are shown in Appendix Table 4.
3.9 MAIN STATISTICAL ANALYSIS METHODS USED
Difference-in-difference model
The difference-in-difference (DID) model is used to estimate the effect of an intervention or 
treatment, by comparing the changes in outcomes over time between a population that is 
enrolled in an intervention group and a control group (96). In Study I, the DID model was 
used regarding the FBG levels, mean EQ VAS score, and EQ-5D-3L index, to test whether 
there were differences in outcomes between the intervention and control group before and 
after the intervention. The DID model was adopted in Study II to test for differences in 
outcomes between the intervention and control group before and after the intervention 
regarding the diabetes knowledge score and FBG level. In Study III, to test for differences in 
outcomes between the intervention and the control group before and after the intervention 
regarding the knowledge score, attitude score, and practice score, a crude DID model without 
adjustment was adopted.
Analysis based on EQ-5D-3L 
Participants who reported “some problems” or “severe problems” on the descriptive system 
in EQ-5D-3L were classified as having “any problems.” The percentage of reporting any 
problems in the EQ-5D-3L dimensions, the mean EQ VAS score, and the EQ-5D-3L index 
were analysed by the Mann–Whitney U test and the Pearson’s χ2-test/Fisher’s Exact test. As 
described in the former section, mean EQ VAS score and EQ-5D-3L index were also 
analysed by DID model. 
Propensity score matching
In Study II, there were significantly more low educated patients in the intervention group 
compared with in the control group. In order to consider potential selection bias and balance 
the distribution of socio-demographic covariates between the intervention and the control 
group, propensity score matching (PSM) was conducted (97). We used 1:1 ratio nearest 
neighbour matching without replacement technique, and included participants’ age, sex, 
marital status, level of education, occupation type, duration of T2DM, and comorbidity as 
potential confounders and entered these into the PSM model.
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Mixed-effects linear regression models
The mixed-effects linear regression model is an extension of simple linear models to allow 
both fixed and random effects, and are mainly used when there is non-independence in the 
data (98). Two mixed-effects linear regression models were adopted to investigate the 
associations between the diabetes knowledge score or FBG level and the interaction of time 
and group. The models were used to study whether these outcomes differed between the 
intervention and control group, at the different time points studied. Both models were 
adjusted for the participants’ socio-demographic characteristics including age, sex, marital 
status, level of education, occupation type, and duration of T2DM. 
3.10 ETHICAL CONSIDERATIONS
Ethical approval was obtained by the Nanjing Medical University Ethics Committee (2015; 
#300). Patient participants received written information about the aim of the project, that 
participation was voluntary and that they could decide to leave the study at any time and for 
any reason. Patients in the intervention area were informed that they would get additional 
diabetes services rather than the routine service, while patients in the control areas were 
informed that there would not be any changes in the diabetes services. All patient participants 
gave informed consent to participate. The research team at NMU was trained and collected 
the data from all patients. Health care professionals in PHC were invited to participate in the 
project. Those included in the intervention group, were informed that they would have some 
extra work to do in the following year. Two questionnaires were offered to them after gaining 
their permission. 
To protect confidentiality, all analyses were carried out on group level, and traceability to 
individuals is therefore not possible.
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4 FINDINGS
4.1 THE IMPACT ON DIABETES KNOWLEDGE SCORE AND FBG LEVEL 
AMONG PATIENTS WITH T2DM (STUDY I, II, IV)
In the analysis for patients in all three counties at the first follow-up, the diabetes knowledge 
score increased significantly in the intervention group, while FBG level decreased 
significantly in the intervention group compared to the control group. At baseline data 
collection, the control group had a higher mean diabetes score than in the intervention group 
(5.36 vs. 4.77). After the one-year implementation of the intervention, the mean diabetes 
knowledge score in the intervention group increased to 5.57. In contrast, the mean diabetes 
knowledge score decreased to 5.25 in the control group. The DID model showed that the 
diabetes knowledge score increased significantly more in the intervention group than in the 
control group (DID = 0.91 (CI95 % 0.64–1.18)). The FBG level in both groups decreased 
after one year. However, only in the intervention group, the FBG level dropped significantly, 
with the mean difference -0.58 mmol/l, (CI95% -0.75, -0.38). Therefore, the FBG level 
decreased significantly more in the intervention group than in the control group, (DID = -0.53 
mmol/l (CI95 % -0.90 to -0.16)). Regarding the two-year impact of the intervention on the 
diabetes knowledge score and FBG level, positive associations were found between diabetes 
knowledge score and the interaction of time and group, the effect size was 0.96 (CI95% 0.69 
to 1.24) in 2016 and 1.14 (CI95% 0.87 to 1.42) in 2017. However, the intervention had a 
positive impact on lowering participants’ FBG level in the intervention group only in 2017, 
with an effect size of -0.46 (CI95% -0.90 to -0.02). 
The intervention had a differential impact on FBG level for patients in different counties, 
both at the first and second follow-up. Patients in Jingjiang county had a different trend of 
FBG level at one-year follow-up. The FBG level decreased in the intervention group (mean 
difference = -0.41), while it increased in the control group (mean difference = 0.77) for 
patients in Jingjiang county. On the contrary, patients in Huaiyin and Gaochun counties had a 
decrease in FBG level in both the intervention and control groups. When comparing the FBG 
level in Huaiyin and Gaochun counties regarding the two-year impact, the intervention had a 
positive impact on controlling FBG level in the intervention group, the effect size was -0.76, 
(CI95% -1.32 to -0.19). 
There was also a differential impact among individual patients. Improvement regarding the 
FBG level was greater among females (from 8.3mmol/l to 7.9mmol/l), married patients (from 
8.2mmol/l to 7.9mmol/l), low educated patients (from 8.4mmol/l to 8.0mmol/l), and patients 
who were farmers or house working (from 8.4mmol/l to 8.0mmol/l), than among other 
patients. 
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4.2 THE IMPACT ON HRQOL AMONG PATIENTS WITH T2DM (STUDY I)
The analysis for EQ-5D-3L was conducted only in Jingjiang county. The mean EQ VAS 
score (from 74.8 to 77.2) and EQ-5D-3L index (from 0.87 to 0.90) increased among patients 
in the intervention group after one year. However, in the DID analysis there was no 
difference between the intervention and the control group regarding the mean EQ VAS score 
and EQ-5D-3L index at one-year follow-up. Fewer patients reported having problems in the 
dimensions mobility (from 22.5% to 11.3%), usual activities (from 13.1% to 3.8%), and 
anxiety/depression (from 23.5% to 14.1%). 
The intervention seemed to differentially benefit some groups of patients, regarding the 
prevalence of any problems by EQ-5D-3L dimensions. Female patients in the intervention 
group improved more in the dimension of mobility and usual activities than male patients. 
The married patients improved in almost all dimensions except self-care, while the single 
patients had no improvement in either of the dimensions. Patients with low educational level 
improved more than high educated patients, regarding the dimension of mobility, usual 
activities, and anxiety/depression. For those who were farmers or house working, 
improvements were found in the dimensions mobility, usual activities, and 
anxiety/depression. On the contrary, patients in other types of work did not improve in any 
dimension after one year. 
Patients in the control group also had some improvements regarding EQ-5D-3L. The EQ-5D-
3L index in the control group increased from 0.89 to 0.93, and the mean EQ VAS score also 
increased in the control group (but not statistically significant). Fewer patients in the control 
group reported having any problem after one year, in the dimension of mobility (from 19.0% 
to 7.6%), usual activities (from 13.3% to 2.4%), pain/discomfort (from 42.4% to 31.4%), and 
anxiety/depression (from 15.7% to 8.6%).
4.3 THE IMPACT AMONG HEALTH CARE PROFESSIONALS IN PHC 
INSTITUTIONS (STUDY III)
The professionals in the intervention group experienced an increase in the diabetes 
knowledge score, with the mean score was 7.3 at baseline and 11.5 at the one-year follow-up. 
The mean diabetes knowledge score also increased slightly in the control group, from 7.3 to 
7.4, but increased significantly more in the intervention group than in the control group after 
the intervention (DID = 3.65). At baseline data collection, the practice score and the attitudes 
score were higher in the control group (14.2 and 8.8, respectively) than in the intervention 
group (13.6 and 8.6, respectively). After one-year implementation of the intervention, the 
mean practice score in the intervention increased to 19.8, higher than in the control group 
(15.0). Similarly, the intervention group had a higher mean attitude score than the control 
group after one year (10.82 vs. 9.34). The DID analysis also showed that the health care 
professionals in the intervention group improved significantly more in their practice score 
and attitudes score than those in the control group (DID = 5.33 and 1.71, respectively). 
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Regarding the proportion of being able to provide different types of diabetes services, there 
was a substantial and significantly higher proportion of participants able to provide services 
in the intervention group than in the control group, for all types of services, except T2DM 
emergency treatment. At baseline, there was no significant difference between the 
intervention group and the control group. At one-year follow-up, the proportion of 
professionals being able to provide seven types of diabetes service (diabetes diagnoses, 
diabetes classification, insulin treatment, oral hypoglycemic agents, early control for T2DM, 
T2DM complication treatment, and T2DM non-drug therapy) in the intervention group had 
increased, compared to the proportion at baseline. 
24
5 DISCUSSION
The educational intervention had a positive impact in improving diabetes knowledge, 
lowering FBG levels and improving HRQoL among patients with T2DM at one-year follow-
up, especially among females and those in lower socioeconomic groups. A long-term (two 
years) positive impact was also found on diabetes knowledge and FBG level. Moreover, the 
intervention had a positive impact among health care professionals in PHC on their 
professional diabetes knowledge, attitudes and practices regarding the intervention, and types 
of services they were able to provide. 
5.1 IMPACT AMONG PATIENTS WITH T2DM
The increased collaboration between the county-level hospital and PHC services, along with 
an educational intervention among patients with T2DM, had a positive impact on the diabetes 
knowledge and FBG levels among patients in the intervention group compared to the control 
group, at one-year follow-up. There was no process evaluation during the implementation of 
the intervention, and we did not have detailed information about how patients participated, 
for example the adherence to the intervention (such as the attendance rate for the education 
lectures). In addition, we have no information as to whether the patients who attended the 
lectures talked about contents of the lecture to those in the control group or those who did not 
attend the lecture. As a result, we do not know whether the improvement of FBG level and 
diabetes knowledge could fully be explained by the intervention. The level of changes in 
diabetes knowledge in this study is similar to that observed in previous studies in different 
settings, that showed a significant improvement in diabetes knowledge, after a short-term 
educational intervention among patients with T2DM (59,99-101). However, both Study II 
and Study IV had a longer duration of the intervention and had more participants than the 
other studies. Cai et al. conducted an educational intervention for T2DM patients in urban 
China (59), and found that the intervention improved the blood glucose level and level of 
diabetes knowledge, which is similar to what we found in Study I and II (59). However, 
Study I and II assessed the one-year impact in rural China, while the intervention in the Cai et 
al. study was conducted in urban settings for only three months (59). 
The intervention also had a positive impact on the diabetes knowledge score and FBG levels 
among patients in the intervention group compared to the control group, at two-year follow-
up. The FBG level decreased significantly in both the intervention and control groups at the 
first follow-up, but increased again in both groups at the second follow-up. Some external 
factors may have affected those results. During 2015 to 2016, Huaiyin and Gaochun county 
participated in a national government initiative project held by the National HFPC (102), 
which aimed to encourage local HFPCs to establish a comprehensive prevention and control 
demonstration zone for chronic disease. This may have contributed to the observed decrease 
in the FBG level in 2016 for participants both in the intervention and control group (102). 
The reason for the increase of the FBG level at the second follow-up is not clear. An 
international literature review found that various factors, including illiteracy and lack of 
knowledge at baseline, posed a great challenge to effective health education with sustained 
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effects (103). Therefore, low educational level and lack of awareness of T2DM among 
patients may weaken the improvement brought by the intervention. We found a long-term 
effect in Gaochun county in 2017, but not in Huaiyin county. Gaochun may have had a better 
situation regarding diabetes care, as it has a higher health budget. Moreover, as part of 
Nanjing city (the capital city of Jiangsu province, with the largest number of level-3 
hospitals), Gaochun has good cooperation with the large city-level hospitals (104). Some 
previous studies have also reported a long-term impact on blood glucose control of 
educational interventions for patients with T2DM in China (109,110), both of which reported 
a significant decrease in the blood glucose level among patients with the intervention. There 
are also similar studies in other countries (105-108). Johnson et al. conducted a two-year 
educational intervention for T2DM patients in the United States, and found that the blood 
glucose level (HbA1c), for patients receiving the education was significantly lower than 
among patients not receiving education, after two years of observation (105). However, a 
study in the United Kingdom showed no significant difference in the HbA1c level between 
patients with a structured group education programme and patients with usual care, at 3-year 
follow-up (106). The different design of the interventions may be one reason to explain the 
different impacts on the blood glucose level. 
Some aspects of HRQoL measured by EQ-5D-3L were also improved in the intervention 
group compared to the control group in our study, but less systematically. The significant 
decrease in the prevalence of reported problems in the dimensions of mobility and usual 
activities may be due to the increased information and knowledge about physical exercise, 
healthy diet, and the importance of proper drug use in the intervention group. The mean EQ 
VAS score increased in the intervention group, which may indicate that the participants 
perceived that their health improved after having had more information and instructions about 
physical activity, diet, healthy lifestyle, and diabetes self-management. 
Participants in the control group had a deterioration in the FBG levels and in the prevalence 
of reported problems in some EQ-5D-3L dimensions, but also improved in mean EQ VAS 
score and the EQ-5D-3L index. When comparing the intervention and control groups, it is 
surprising to see a decreased proportion of reported problems in the EQ-5D-3L dimensions 
and improved mean EQ VAS scores and EQ-5D-3L index in both the control and 
intervention groups, as the control group received no intervention. This might partly be 
explained by compositional differences between the intervention and the control group — 
participants in the control group were younger, and more of them were married and had a 
higher educational level, all of which are associated with better HRQoL (111,112). Another 
possibility, as no intervention was provided to the control group, might be that the changes in 
HRQoL may be due to the “Hawthorne effect” (113). We found only one educational 
intervention study which assessed EQ-5D among T2DM patients (114). Christoffersen et al. 
evaluated the effect of a participatory group-based education programme for T2DM patients, 
at three-months and 12-months follow-up (114). The EQ-5D-5L instrument was adopted in 
the study, but the results did not differ significantly between the intervention and control 
group (114). 
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There were also signs of a differential impact of the intervention by county, which may 
reflect differences in the local implementation of the intervention between counties, the 
different levels of economic development of the different counties, or the differing baseline 
level of diabetes knowledge in the different counties. Although the content of the intervention 
was the same in the different counties, as the implementation of the intervention was in the 
hands of the local HFPCs, it is possible that the quality and intensity of implementation 
varied between the counties. 
There was also a differential impact among patients. The FBG level and some aspects of 
HRQoL measured by EQ-5D-3L improved more among females, those who were married, 
those with low education, and those in farming or house working. This might indicate that 
this intervention was better suited for persons with a low educational level than with a high 
educational level, and for farmers in rural China. The changes in blood glucose levels at one-
year follow-up are similar to those observed in previous studies (115-119).
5.2 IMPACT AMONG HEALTH CARE PROFESSIONALS IN PHC
The professional knowledge improved significantly in the intervention group, indicating that 
the professional skills training sessions positively affected the participating health care 
professionals. Another possible explanation for the improvement is that the design of the 
knowledge questions was entirely based on the training sessions. Therefore, it might have 
been easier for those who attended the training sessions to get a higher score, although it 
might not reflect their real ability. However, health care professionals in the intervention 
group were able to provide more types of services than in the control group. The improved 
practice score and attitude score indicate that the participating health care professionals in the 
intervention group had more positive perspectives than those in the control group regarding 
cooperation with county-level hospitals, including transfer treatment, communication, and 
using the new information delivery system. This suggests that the intervention had a positive 
impact. 
The local HFPC provided rewards for health care professionals who participated in the study, 
including a bonus (about 2000 RMB per year) and promotion opportunity. The larger project 
included interviews with health professionals (not included in this PhD thesis), and many 
interviewees responded that the bonus was not much, but the promotion opportunity was a 
big encouragement for them to actively participate. Therefore, it is possible that the 
improvement in the professional knowledge and skills, practices and attitudes toward the 
intervention was also partly caused by those rewards. A previous study in rural China showed 
a similar result as the present study. After an 18-months training session for PHC doctors 
there was an improvement in professional skills and an increased ability to provide a better 
quality of diabetes care (120). The design of the education training session in the present 
study is similar to peer education training, which is commonly used in chronic disease care in 
many countries (121,122). However, Study III also emphasized the collaboration between 
county-level hospitals and PHC institutions and is the only one to our knowledge which 
combined education sessions and cooperation with hospital-level professionals (64-66). 
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5.3 METHODOLOGICAL CONSIDERATIONS
This PhD thesis aimed to contribute to knowledge on diabetes care in rural China settings. In 
response to the urgent need for knowledge and management strategies for patients with 
T2DM, educational interventions supported by experts may be a way to strengthen diabetes 
care and enhance the collaboration between PHC and hospital care in China (123). Many 
studies in recent years have focused on educational interventions for diabetes patients in 
urban China to improve glucose control and empower patients themselves to better manage 
their disease (63,124). However, few studies have focused on patients with T2DM in rural 
areas in China (124). Moreover, the evidence supporting the impact of educational 
interventions is limited to short-term studies of typically under one year. Few studies with a 
long-term follow-up have been found in different settings (105-108). We only found two 
Chinese language studies which focused on urban China with an educational intervention 
longer than one year (109,110). No study was found with such long-term intervention in rural 
China. The current project was conducted in rural China, where the increase of T2DM is 
rapid. The intervention for patients lasted for two years in two counties, which allowed us to 
analyse the long-term impact of the educational intervention. Therefore, the project may be a 
contribution to current research. 
The doctors and nurses in PHC institutions in rural China have a low level of training for 
chronic conditions, commonly in the lower level of medical education (28). As vital parts of 
delivery health care service, the knowledge and skills, as well as the ability to provide 
different types of services, become extremely important for health care professionals (32). 
Study III aimed to improve the professional knowledge and skills, by the collaboration with 
the hospital level, through the educational intervention for health care professionals in PHC 
in rural China. The results also indicated a positive impact among those professionals, and 
that it may be possible to implement in other rural areas in China. In the current project, the 
county-level hospital provided experienced doctors to educate the patients and health care 
professionals in PHC, which showed a positive impact both on T2DM patients and health 
professionals in PHC. County-level hospitals usually are able to attract more resources and 
higher quality resources (health workforce and health technologies) than PHC institutions 
(125). On the contrary, services delivered by PHC are deemed to be of poor quality, due to 
the shortage of health care resources (126). Therefore, collaboration between county-level 
hospitals and PHC institutions might be an effective way to shift services and resources from 
hospitals to PHC, and to provide more accessible as well as better-quality service for patients. 
The project was not a randomized controlled trial (RCT), but based in a “real-life setting”. 
This may be both a limitation and an advantage to the study. There are many discussions 
regarding the RCT and studies in real-life settings (or real-life studies), each of them having 
their advantages and disadvantages (127-129). RCTs are commonly recognized as the “gold 
standard” for evaluating treatment outcomes because of their rigorous experimental design, 
randomization and blinding, and rigorous analysis methods (130). However, an RCT is 
usually implemented under optimally controlled conditions in the absence of confounding 
factors: highly selected patients, optimal management conditions, and ideal settings— thus 
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the information provided by RCT is “efficacy” under certain conditions different from real 
life (131). Studies in real-life settings can be considered complementary with RCTs (129), 
and reflect how treatments or interventions are administered in normal routine work and 
everyday life (127). A non-selected population can be included, with a larger sample size 
than RCT. Along with the natural practice setting, and allowing long duration, studies 
adopting a real-life setting may be used in health policy research (131). In the current project, 
it was not possible to conduct an RCT because of the complicated background factors of the 
project and the high cost of RCTs. Implementing an intervention in a real-life setting also 
may facilitate policy learning, and may give a more realistic assessment of whether an 
intervention is feasible under such circumstances. Nevertheless, the limitations of real-life 
settings cannot be ignored. In our studies, the intervention was implemented locally and the 
implementation was outside the control of the research team. Hence, the scope and intensity 
of implementation may have varied between different counties and townships, which may 
have affected the results. On the other hand, after the collaboration with NMU, the local 
HFPC gained knowledge and experience about supporting diabetes care in the administrative 
and management aspects, which may facilitate continued and sustained local implementation 
of the new way of working.
In order to deal with the different compositions between the intervention and control groups, 
caused by the non-selected population in the real-life setting, we used propensity score 
matching (Study II), DID model (Study I, II, and III), mixed-effects regression model (Study 
IV) and stratified analysis (all four studies) to deal with potential confounding. 
Patients with T2DM in the control group also had improvements in certain outcomes, some 
aspects of HRQoL measured by EQ-5D-3L, EQ VAS, and EQ-5D index. This might be 
partly explained by the Hawthorne effect, meaning that participants may modify their 
behaviour in response to their awareness of being observed (113). The Hawthorne effect is a 
limitation in the project, which may underestimate the impact of the intervention. 
Another limitation is that external influences, not possible to control in this project, may have 
affected the results observed. One example is the national initiative on chronic disease care in 
2016, described for Huayin and Gaochun county. This coincided in time with the 
improvement of the diabetes knowledge score and FBG levels, observed in both the 
intervention and the control group in both counties in 2016. It is not possible to disentangle 
whether this improvement in FBG and diabetes knowledge was mainly a result of the 
intervention or of the national initiative.
The project was based on the collaboration between the NMU and the local HFPC. The 
research team in NMU designed the intervention, while the county-level HFPC controlled the 
implementation, and details of the implementation are lacking. As a result, the 
implementation is likely to have differed in the three counties, which may have affected the 
results observed. A more intensive implementation would be likely to lead to a stronger 
impact on the studied outcomes, but as we did not measure the degree of implementation this 
could not be studied. 
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We used self-designed questionnaires for patients and health care professionals to collect 
information regarding the intervention, which could be both an advantage and a limitation. 
The self-designed questionnaires were designed specifically for the intervention, so they 
precisely captured the issues we focused. Furthermore, some existing questionnaires (e.g., 
diabetes knowledge) were considered too difficult for our patients as many of them had low 
educational level. However, the validity and reliability of the questionnaires may be 
questioned as they were never used before the current project. The Cronbach alpha was 
calculated for the nine questions for patients’ diabetes knowledge, 13 questions related to 
diabetes professional knowledge, and for the eight questions related to services which the 
health care professionals provide. The Cronbach alpha showed acceptable reliability for the 
self-designed questionnaires.
5.4 LESSONS LEARNED
Some general reflections can be made from this PhD project. In order to improve the care for 
patients with T2DM (and likely also patients with other chronic diseases) in rural China, the 
results from this study suggests some potential areas for interventions and further studies.
 Strengthening the collaboration between hospital care and PHC 
The inequality in the distribution of health care resources between urban and rural 
areas remains a major issue in China, where hospital care dominates (134). Bringing 
diabetes care and hospital resources (experienced experts and advanced equipment) to 
the PHC level could be an effective way to improve the quality of diabetes care in 
rural China. In the current project, the county-level hospital provided experienced 
doctors to educate the patients and health care professionals in PHC, which had a 
positive impact both for T2DM patients and health professionals in PHC. The 
collaborations could also include level 3 hospitals (Figure 1) in urban areas, i.e. 
collaboration between rural and urban areas in China.
 Investing in education for health care professionals in PHC institutions 
Study III showed that improved professional knowledge and skills made the doctors 
in PHC institutions able to provide more types of diabetes care services for patients. 
Health care professionals in PHC usually have lower level medical education, and 
have a heavy workload (28). Investing in education for them may improve the 
delivery of diabetes care.
 Enhancing the diabetes education for patients with T2DM 
China has put a lot of effort into medication and treatment for diabetes, while the 
awareness and knowledge are lacking for patients, especially in rural areas (4). The 
improved diabetes knowledge, FBG level, and HRQoL in our studies indicated that 
diabetes education for patients had a positive impact. 
 Establishing diabetes registry for all patients 
China has no national data registry for patients with T2DM. Many of the health care 
professionals in PHC suggested to establish a database for T2DM patients to help 
them assess the quality of the service provided, with information about blood glucose 
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level, history of medication, inpatient/outpatient records, examination results, and life 
style change. Sweden has a nationwide database for all T2DM patients, a  National 
Diabetes Registry (NDR), which can provide an example for China (133). The NDR 
is a key factor for quality improvement in diabetes care in Sweden, as it provides an 
assessment of diabetes care and offers GPs and diabetes nurses individualised 
information for each patient (133).
 Reforming the management of local HFPC 
When implementing the intervention, the local HFPC was not able to provide detailed 
information on the implementation. The situation may improve in the future as the 
central government has launched a reform in improving management for health care 
authorities (135). More efforts should be put in daily administrative work and 
recording more details in the management. 
5.5 FUTURE RESEARCH
The educational intervention provided a model for how similar interventions could be 
conducted to assess their impact among both patients with T2DM and health care 
professionals in PHS, in other rural settings in China. The findings of the four studies also 
suggest questions that future research could address:
 Could a similar intervention have a positive impact in less-developed areas, for example, 
the north-west province in China?
 How does a similar intervention impact on patients’ satisfaction with care? 
 How does a similar intervention impact out-of-pocket expenses for diabetes care?
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6 CONCLUSIONS
The current project focused on T2DM in rural China and has contributed to knowledge on the 
impact of educational interventions for both patients and health care professionals in PHC. 
The educational intervention, with improved collaboration between county-level hospitals 
and PHC institutions, and health education to patients, had a positive impact in improving 
diabetes knowledge, FBG levels and some aspects of HRQoL among T2DM patients. 
Furthermore, the intervention had a positive impact among health care professionals in PHC 
on their professional diabetes skills, knowledge, attitudes, practices, and types of services 
they were able to provide. The intervention among patients seemed to differentially benefit 
females, married persons, low educated persons, and those in farming or house working more 
than other groups. The impact of the intervention among patients also differed between the 
counties at one-year follow-up, and a two-year positive impact was found only in one county 
(Gaochun). Improved collaboration between county-level hospitals and PHC, with 
educational efforts both to health care staff and patients with T2DM, appears to be a feasible 
and effective way of improving care of patients with T2DM in rural areas in China.
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9 APPENDIX
Appendix Table 1. Patient diabetes knowledge questionnaire
No. Question Options
1. Do you know the diagnose criteria of diabetes (FBG)? † Yes, it is ____ mmol/l I do not know
2. Is dizziness a symptom of diabetes? Yes No I do not know
3. Is obesity a risk factor for diabetes? Yes No I do not know
4. Do people with a diabetes family history have higher risk of diabetes? Yes No I do not know
5. Is smoking or drinking a risk factor for diabetes? Yes No I do not know
6. Will monitoring your blood glucose help to control diabetes? Yes No I do not know
7. Will eating high fat or high sugar food help to control diabetes? Yes No I do not know
8. Will you be blind if the diabetes cannot be controlled? Yes No I do not know
9. Is it necessary to keep using medication if you have already controlled your blood glucose level? Yes No I do not know
† The answer “Yes”, and FBG greater than 7 mmol/l, is classified as the right answer.
Bold font is the right answer for question 2-9.
Appendix Table 2. Professional knowledge questionnaire
No. Question Options
1 Which of the following options is not a typical symptom of T2DM?
A. Too much drinking
B. Too much urine
C. Too much eating
D. Lose weight
E. Dizziness
2 Which of the following options is not a chronic complication of T2DM?
A. Diabetic nephropathy
B. Diabetic foot
C. Diabetic cardiomyopathy
D. Diabetic neuropathy
E. Diabetic ketoacidosis
3
According to the Chinese guidelines for diabetes prevention 
and treatment, which of the following options is the goal for 
glucose control measured by HbA1c?
A. <= 6.5%
B. >= 6.5%
C. <= 7.5%
D. >= 7.5%
4 Which of the following options is the reason of polydipsia for diabetes patients?
A. Malabsorption of renal tubular
B. High crude urine osmotic pressure
C. Too much water intake
D. Reduced aldosterone secretion
E. Lack of vasopressin
5 What is the best insulin treatment plan for glucose control?
A. Premixed insulin injection twice a 
day.
B. Short-acting insulin injection 3 
times a day
C. Short-acting insulin injection 4 
times a day
D. Short-acting insulin injection 3 
times a day (before 
breakfast/lunch/dinner) + long-
acting insulin before go to bed
6 What is the main side effect of biguanides?
A. Lactic acidosis
B. Hypoglycemia
C. Gastrointestinal reaction
D. Allergic eruption
Continued in the next page
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(Continued) Appendix Table 2. Professional knowledge questionnaire
7 Which of the following patients are not suitable for insulin treatment?
A. Type 1 diabetes
B. Type 2 diabetes for long time, and 
BG are higher than criteria
C. New diagnosed T2DM with high 
BG
D. Suffering the complication
8
Scenario: A patient was in a coma due to diabetic 
ketoacidosis. After the insulin treatment, he/she revived, but 
felt palpitation, hungry, and became unconsciousness again. 
What should you do?
A. Increase the insulin dosage
B. Add in glibenclamide
C. Intravenous drip with sodium 
bicarbonate
D. Fingertip blood glucose test
E. Use respiratory stimulant
9
Scenario: female patient, been diagnosed for 10 years, felt 
toes numb in the last 2 months, acupuncture-like pain in 
double legs and urine incontinence. Physical examination 
result: malnutrition, interosseus muscle atrophy in both 
hands, muscle strength level IV, FBG 14.5mmol/L. Which of 
the following statements is correct?
A. Diabetics complicating 
cerebrovascular accident
B. Diabetic neuropathy
C. Diabetic microangiopathy
D. Diabetic autonomic neuropathy
E. Diabetic sensory neuropathy
10
Scenario: female patient, has T2DM, irregular hypoglycemic 
drug intake, has fever and cough for 4 days, with 
unconsciousness. Physical examination results: 
unconsciousness, BG = 34 mmol/L, Na = 155 mmol/L, blood 
urea nitrogen = 14.5 mmol/L. Which of the following options 
is the right diagnosis?
A. Ketoacidosis
B. Hyperosmolar nonketotic diabetic 
coma
C. Stroke
D. Lactic acidosis
E. Uremia
11
Scenario: male patient, 16 years old, with “overeating, 
overdrinking, polyuria, losing weight” for 3 months. BG = 
21.7 mmol/L, positive urine-glucose, positive urine ketone. 
Which treatment is the most suitable one?
A. Sulfonylureas drugs for diabetes
B. Biguanides
C. Glucosidase inhibitor
D. Thiazolidinedione
E. Insulin
12
Scenario: female middle-aged patient, obesity, with less 
obvious “overeating, overdrinking, polyuria, losing weight”. 
FBG = 6.0 mmol/L. 2h postprandial blood glucose = 9.2 
mmol/L, urine glucose: (-). Which treatment is the most 
suitable one?
A. Oral hypoglycemic agent
B. Injection of insulin
C. Traditional Chinese medicine
D. Physical exercise
E. Diet therapy
13
Scenario: female patient, 23 years old, has T1DM. Been in a 
coma after interrupted insulin intake for 3 days. BG = 30.3 
mmol/L. Which of the diagnoses should be considered 
priority?
A. Diabetic ketoacidosis and coma
B. Cerebrovascular accident
C. Hypoglycemic coma
D. Ischemic heart failure
E. Insensible diabetics with high 
osmotic pressure
Appendix Table 3. Service types health care professionals can provide
Can you provide the service?
No. Type of service Yes No
1 Diabetes diagnose 　 　
2 Diabetes classification 　 　
3 Insulin treatment 　 　
4 Oral hypoglycemic agents 　 　
5 Early control for T2DM 　 　
6 T2DM complication treatment 　 　
7 T2DM non-drug therapy 　 　
8 T2DM emergency treatment 　 　
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Appendix Table 4. Questions on attitudes and practices regarding the intervention
Response level
　Questions
Worst Best
Attitudes change
1 How do you think about the communication with the county level hospital for transfer treatment? 　 　 　 　 　
2 Do you think it is helpful for patients to enhance the communication between facilities? 　 　 　 　 　
3 What do you think about the patients’ information delivery between three-level health care facilities? 　 　 　 　 　
Practice change
1 In the last 12 months, have you ever transferred any patient? 　 　 　 　 　
2 Are you familiar with the cooperation and communication between different health care facilities? 　 　 　 　 　
3 How often do you communicate with doctors from other facilities? 　 　 　 　 　
4 Do you have experience of coordinating with doctors from other institutions and providing service to patients? 　 　 　 　 　
5 Do you have experience of providing service with a doctor from another facility? 　 　 　 　 　
6 Are you familiar with the doctors who are proficient at diabetes and hypertension in county-level hospitals? 　 　 　 　 　
